- Home
- NAGE vs OPY Comparison
NAGE vs OPY Comparison
Compare NAGE & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- OPY
- Stock Information
- Founded
- NAGE 1999
- OPY 1881
- Country
- NAGE United States
- OPY United States
- Employees
- NAGE N/A
- OPY 3012
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- OPY Investment Bankers/Brokers/Service
- Sector
- NAGE Health Care
- OPY Finance
- Exchange
- NAGE Nasdaq
- OPY Nasdaq
- Market Cap
- NAGE 766.4M
- OPY 820.6M
- IPO Year
- NAGE N/A
- OPY N/A
- Fundamental
- Price
- NAGE $10.10
- OPY $78.94
- Analyst Decision
- NAGE Strong Buy
- OPY
- Analyst Count
- NAGE 3
- OPY 0
- Target Price
- NAGE $17.00
- OPY N/A
- AVG Volume (30 Days)
- NAGE 791.2K
- OPY 52.2K
- Earning Date
- NAGE 10-30-2025
- OPY 10-24-2025
- Dividend Yield
- NAGE N/A
- OPY 0.93%
- EPS Growth
- NAGE N/A
- OPY 41.03
- EPS
- NAGE 0.22
- OPY 7.71
- Revenue
- NAGE $116,303,000.00
- OPY $1,400,370,000.00
- Revenue This Year
- NAGE $29.05
- OPY N/A
- Revenue Next Year
- NAGE $21.09
- OPY N/A
- P/E Ratio
- NAGE $44.84
- OPY $10.04
- Revenue Growth
- NAGE 35.90
- OPY 14.40
- 52 Week Low
- NAGE $3.18
- OPY $47.39
- 52 Week High
- NAGE $14.69
- OPY $79.32
- Technical
- Relative Strength Index (RSI)
- NAGE 56.52
- OPY 65.43
- Support Level
- NAGE $9.42
- OPY $76.64
- Resistance Level
- NAGE $9.92
- OPY $79.32
- Average True Range (ATR)
- NAGE 0.40
- OPY 2.41
- MACD
- NAGE 0.06
- OPY 0.59
- Stochastic Oscillator
- NAGE 98.08
- OPY 91.15
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.